MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Single and Multiple Dose Study of Canagliflozin in Healthy Volunteers

First Posted Date
2011-01-24
Last Posted Date
2012-11-30
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
27
Registration Number
NCT01281579

A Study of Cisapride in Premature Infants With Feeding Problems

Phase 4
Terminated
Conditions
Infant, Premature
Infant, Newborn
Interventions
Drug: Placebo
First Posted Date
2011-01-24
Last Posted Date
2011-01-24
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
8
Registration Number
NCT01281566

An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options

Phase 4
Terminated
Conditions
Gastroparesis
Interventions
Drug: Placebo
First Posted Date
2011-01-24
Last Posted Date
2011-01-24
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
20
Registration Number
NCT01281540

A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease

Phase 4
Terminated
Conditions
Gastroesophageal Reflux
Interventions
Drug: Placebo
First Posted Date
2011-01-24
Last Posted Date
2011-01-24
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
6
Registration Number
NCT01281553

A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Canagliflozin/Metformin
First Posted Date
2011-01-10
Last Posted Date
2013-07-29
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
18
Registration Number
NCT01273571

A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus

Phase 1
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
First Posted Date
2011-01-10
Last Posted Date
2013-04-22
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
28
Registration Number
NCT01273558

A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model

Phase 2
Completed
Conditions
Asthma
Interventions
First Posted Date
2010-11-16
Last Posted Date
2015-12-21
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
22
Registration Number
NCT01241422

A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
First Posted Date
2010-11-16
Last Posted Date
2012-10-30
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
78
Registration Number
NCT01241409
© Copyright 2025. All Rights Reserved by MedPath